Thus, there is a consensus between the TCGA and GSE65858 cohorts that CAMK2N1, CALML5, and FCGBP are significant candidates for HNSCC biomarkers. This evidence concerns the gene CAMK2N1 and head and neck squamous cell carcinoma.